Credit Suisse’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-76,764
| Closed | -$257K | – | 3156 |
|
|
2023
Q1 | $257K | Buy |
76,764
+2,430
| +3% | +$8.14K | ﹤0.01% | 3032 |
|
|
2022
Q4 | $358K | Buy |
74,334
+19,842
| +36% | +$95.4K | ﹤0.01% | 2932 |
|
|
2022
Q3 | $310K | Buy |
54,492
+450
| +0.8% | +$2.56K | ﹤0.01% | 3050 |
|
|
2022
Q2 | $383K | Buy |
54,042
+37,772
| +232% | +$268K | ﹤0.01% | 2991 |
|
|
2022
Q1 | $118K | Sell |
16,270
-2,991
| -16% | -$21.7K | ﹤0.01% | 3445 |
|
|
2021
Q4 | $172K | Buy |
19,261
+1,863
| +11% | +$16.6K | ﹤0.01% | 3470 |
|
|
2021
Q3 | $610K | Buy |
17,398
+5,420
| +45% | +$190K | ﹤0.01% | 2880 |
|
|
2021
Q2 | $257K | Buy |
+11,978
| New | +$257K | ﹤0.01% | 3340 |
|